APLN and persistent truncus arteriosus: Apelin-13 was identified as target of miR-503 by luciferase assay, and antagomiR-503 treatment in TAC mice improved cardiac function and suppressed both TGF-β and CTGF expression, therefore, miR-503 has the property of promoting cardiac fibrosis in TAC mouse model.